Trials / Conditions / Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
4 registered clinical trials studyying Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungo NCT07003100 | City of Hope Medical Center | — |
| Active Not Recruiting | Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome NCT04652960 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogam NCT04541017 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides NCT03695471 | Mayo Clinic | Phase 2 |